Circulating Tumor Cells Market Segment Analysis By Technology, Application, Product, Specimen, Region And Forecast Till 2027
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgIlvlhuvHJEurmtj5GRTbS8yZT5tVu7lpa9_uGMdnKo2lZ5_j4WurFapefQvpuQVBu-_RMORGxm2cClurWeGGreLAGDmjeh3ByDF5JzFjU7-UeUvYe0hkVbvlFJgpqXLfJe9uxi0Z_52Tr/s320/1080x630_Circulating+Tumor+Cells+Market_Vishal_Pradnya_August.png)
San Francisco, 9 Aug 2021: The Report Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Technology, By Application (Clinical, Research), By Product, By Specimen (Bone Marrow, Blood), By Region, And Segment Forecasts, 2021 - 2027 The global circulating tumor cells market size is expected to reach USD 18.3 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.7% from 2021 to 2027. Many potential applications of CTCs in pre-diagnosis, pretreatment, and intra- and post-treatment provide lucrative growth opportunities to players involved in the development of CTC enrichment and isolation products Research organizations are engaged in endeavors aimed at developing CTC-based tests to improve cancer diagnosis in terms of efficiency and speed. Furthermore, the growing demand for minimally invasive diagnostic procedures is anticipated to propel investments by key stakeholders in this area. CTC-based